Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Engage with mental illness

It was refreshing to see the attention you gave to schizophrenia (PJ 2014;292:342). It would be great to see pharmacists engaging with the condition. Does anyone really know, though, how to address these serious mental illnesses?

In “The life scientific” on BBC Radio 4, Sir Robin Murray from the Institute of Psychiatry said that, in the 1980s, psychiatrists were actually trained not to engage patients about their symptoms. Those doctors are still very much around and there always seems to be silence around mental illness.

It is not for nothing that quetiapine is so called — the name conjures up thoughts of enforced quiet. Taboo, silence, stigma and shame are fearful barriers to overcome.

It is welcome to see attention going the way of mental illness, but is should be a genuine and sincere attempt and not just another of these ventures in which there is more honour in the breach than the observance.

Andrew Low


Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11136845

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.